☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
App
Advertisement
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
technology
Merck Signs a ~$1B Pact with Janux to Develop Cancer Therapies Using T Cell Engager Technology
December 21, 2020
Merck Signs a ~$1B Pact with Janux to Develop Cancer Therapies Using T Cell Engager Technology
December 21, 2020
Novartis Signs an Agreement with Dyno to Develop Novel AVV Therapies Utilizing AI Technology for Ocular Diseases
May 12, 2020
Novartis Signs an Agreement with Dyno to Develop Novel AVV Therapies Utilizing AI Technology for Ocular Diseases
May 12, 2020
DIA India Medical Devices Conference from 21-22 February 2020 I New Delhi, India
February 13, 2020
DIA India Medical Devices Conference from 21-22 February 2020 I New Delhi, India
February 13, 2020
Load more...
Back to Home